Angiopoietin-like proteins: A comprehensive look

Frontiers in Endocrinology

Volumn 5, Issue JAN, 2014, Pages

  Santulli, Gaetano ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Columbia University Medical Center ^*  (United States)

Author keywords

Angiopoietin like proteins; Angptl; Cancer; Glucose homeostasis; Hematopoietic stem cells; Inflammation; Insulin; Metabolism

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ANGIOPOIETIN; ANGIOPOIETIN LIKE PROTEIN 1; ANGIOPOIETIN LIKE PROTEIN 2; ANGIOPOIETIN LIKE PROTEIN 3; ANGIOPOIETIN LIKE PROTEIN 4; ANGIOPOIETIN LIKE PROTEIN 5; ANGIOPOIETIN LIKE PROTEIN 6; ANGIOPOIETIN LIKE PROTEIN 7; ANGIOPOIETIN LIKE PROTEIN 8; BETA CATENIN; FIBROBLAST GROWTH FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; WNT PROTEIN;

ANGIOGENESIS; GENE MUTATION; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLYCOSYLATION; HUMAN; HYPERTRIGLYCERIDEMIA; INFLAMMATION; LIPID METABOLISM; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEINURIA; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GROWTH; ATHEROSCLEROSIS; CANCER STAGING; FATTY LIVER; GLUCOSE METABOLISM; HEMATOPOIESIS; HYPOLIPEMIA; LYMPH NODE METASTASIS; NEOPLASM; SIGNAL TRANSDUCTION;

EID: 84898401971     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2014.00004     Document Type: Short Survey

References (87)

1. Dhanabal M, Larochelle WJ, Jeffers M, Herrmann J, Rastelli L, McDonald WF, et al. Angioarrestin: an antiangiogenic protein with tumor-inhibiting properties. Cancer Res (2002) 62:3834-41.
2. Doi Y, Ninomiya T, Hirakawa Y, Takahashi O, Mukai N, Hata J, et al. Angiopoietin-like protein 2 and risk of type 2 diabetes in a general Japanese population: the Hisayama study. Diabetes Care (2013) 36:98-100. doi: 10.2337/dc12-0166
3. Glazer NL. Exome sequencing links gene mutation in angiopoietin-like protein 3 with low-density lipoprotein cholesterol. Circ Cardiovasc Genet (2011) 4:100-1. doi:10.1161/CIRCGENETICS.111.959510
4. Ortega-Senovilla H, Schaefer-Graf U, Meitzner K, Abou-Dakn M, Herrera E. Decreased concentrations of the lipoprotein lipase inhibitor angiopoietin-like protein 4 and increased serum triacylglycerol are associated with increased neonatal fat mass in pregnant women with gestational diabetes mellitus. J Clin Endocrinol Metab (2013) 98:3430-7. doi:10.1210/jc.2013-1614
5. Zeng L, Dai J, Ying K, Zhao E, Jin W, Ye Y, et al. Identification of a novel human angiopoietin-like gene expressed mainly in heart. J Hum Genet (2003) 48:159-62. doi:10.1007/s10038-003-0033-3
6. Oike Y, Yasunaga K, Ito Y, Matsumoto S, Maekawa H, Morisada T, et al. Angiopoietin-related growth factor (AGF) promotes epidermal proliferation, remodeling, and regeneration. Proc Natl Acad Sci U S A (2003) 100:9494-9. doi:10.1073/pnas.1531901100
7. Peek R, Van Gelderen BE, Bruinenberg M, Kijlstra A. Molecular cloning of a new angiopoietin like factor from the human cornea. Invest Ophthalmol Vis Sci (1998) 39:1782-8.
8. Quagliarini F, Wang Y, Kozlitina J, Grishin NV, Hyde R, Boerwinkle E, et al. Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci U S A (2012) 109:19751-6. doi:10.1073/pnas.1217552109
9. Fu Z, Yao F, Abou-Samra AB, Zhang R. Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family. Biochem Biophys Res Commun (2013) 430:1126-31. doi:10.1016/j.bbrc.2012.12.025
10. Kim I, Kwak HJ, Ahn JE, So JN, Liu M, Koh KN, et al. Molecular cloning and characterization of a novel angiopoietin family protein, angiopoietin-3. FEBS Lett (1999) 443:353-6. doi:10.1016/S0014-5793(99)00008-3
11. Ward NL, Dumont DJ. The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development. Semin Cell Dev Biol (2002) 13:19-27. doi:10.1006/scdb.2001.0288
12. Oike Y, Yasunaga K, Suda T. Angiopoietin-related/angiopoietin-like proteins regulate angiogenesis. Int J Hematol (2004) 80:21-8. doi:10.1532/IJH97.04034
13. Camenisch G, Pisabarro MT, Sherman D, Kowalski J, Nagel M, Hass P, et al. ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo. J Biol Chem (2002) 277:17281-90. doi:10.1074/jbc. M109768200
14. Le Jan S, Amy C, Cazes A, Monnot C, Lamande N, Favier J, et al. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol (2003) 162:1521-8. doi:10.1016/S0002-9440(10)64285-X
15. Zheng J, Umikawa M, Cui C, Li J, Chen X, Zhang C, et al. Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development. Nature (2012) 485:656-60. doi:10.1038/nature11095
16. Kersten S. Regulation of lipid metabolism via angiopoietin-like proteins. Biochem Soc Trans (2005) 33:1059-62. doi:10.1042/BST20051059
17. Tabata M, Kadomatsu T, Fukuhara S, Miyata K, Ito Y, Endo M, et al. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab (2009) 10:178-88. doi:10.1016/j.cmet.2009.08.003
18. Zhang CC, Kaba M, Ge G, Xie K, Tong W, Hug C, et al. Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat Med (2006) 12:240-5. doi:10.1038/nm1342
19. Galaup A, Cazes A, Le Jan S, Philippe J, Connault E, Le Coz E, et al. Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci U S A (2006) 103:18721-6. doi:10.1073/pnas.0609025103
20. Kuo TC, Tan CT, Chang YW, Hong CC, Lee WJ, Chen MW, et al. Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility. J Clin Invest (2013) 123:1082-95. doi:10.1172/JCI64044
21. Kubota Y, Oike Y, Satoh S, Tabata Y, Niikura Y, Morisada T, et al. Cooperative interaction of Angiopoietin-like proteins 1 and 2 in zebrafish vascular development. Proc Natl Acad Sci U S A (2005) 102:13502-7. doi:10.1073/pnas.0501902102
22. Sasaki H, Moriyama S, Sekimura A, Mizuno K, Yukiue H, Konishi A, et al. Angioarrestin mRNA expression in early-stage lung cancers. Eur J Surg Oncol (2003) 29:649-53. doi:10.1016/S0748-7983(03)00106-9
23. Xu Y, Liu YJ, Yu Q. Angiopoietin-3 inhibits pulmonary metastasis by inhibiting tumor angiogenesis. Cancer Res (2004) 64:6119-26. doi:10.1158/0008-5472.CAN-04-1054
24. Lai DM, Li H, Lee CC, Tzeng YS, Hsieh YH, Hsu WM, et al. Angiopoietin-like protein 1 decreases blood brain barrier damage and edema following focal cerebral ischemia in mice. Neurochem Int (2008) 52:470-7. doi:10.1016/j.neuint.2007.08.010
25. Zheng JY, Zou JJ, Wang WZ, Feng XY, Shi YY, Zhao Y, et al. Tumor necrosis factor-alpha increases angiopoietin-like protein 2 gene expression by activating Foxo1 in 3T3-L1 adipocytes. Mol Cell Endocrinol (2011) 339:120-9. doi:10.1016/j.mce.2011.04.002
26. Lee HJ, Kim JH, Kim JH, Martinus RD, Park SH. Angiopoietin-like protein 2, a chronic inflammatory mediator, is a new target induced by TGF-beta1 through a Smad3-dependent mechanism. Biochem Biophys Res Commun (2013) 430:981-6. doi:10.1016/j.bbrc.2012.11.127
27. Tian Z, Miyata K, Tazume H, Sakaguchi H, Kadomatsu T, Horio E, et al. Perivascular adipose tissue-secreted angiopoietin-like protein 2 (Angptl2) accelerates neointimal hyperplasia after endovascular injury. J Mol Cell Cardiol (2013) 57:1-12. doi:10.1016/j.yjmcc.2013.01.004
28. Farhat N, Thorin-Trescases N, Voghel G, Villeneuve L, Mamarbachi M, Perrault LP, et al. Stress-induced senescence predominates in endothelial cells isolated from atherosclerotic chronic smokers. Can J Physiol Pharmacol (2008) 86:761-9. doi:10.1139/Y08-082
29. Ogata A, Endo M, Aoi J, Takahashi O, Kadomatsu T, Miyata K, et al. The role of angiopoietin-like protein 2 in pathogenesis of dermatomyositis. Biochem Biophys Res Commun (2012) 418:494-9. doi:10.1016/j.bbrc.2012.01.052
30. Okada T, Tsukano H, Endo M, Tabata M, Miyata K, Kadomatsu T, et al. Synoviocyte-derived angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis. Am J Pathol (2010) 176:2309-19. doi:10.2353/ajpath.2010.090865
31. Tazume H, Miyata K, Tian Z, Endo M, Horiguchi H, Takahashi O, et al. Macrophage-derived angiopoietin-like protein 2 accelerates development of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (2012) 32:1400-9. doi:10.1161/ATVBAHA.112.247866
32. Aoi J, Endo M, Kadomatsu T, Miyata K, Nakano M, Horiguchi H, et al. Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis. Cancer Res (2011) 71:7502-12. doi:10.1158/0008-5472.CAN-11-1758
33. Endo M, Nakano M, Kadomatsu T, Fukuhara S, Kuroda H, Mikami S, et al. Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis. Cancer Res (2012) 72:1784-94. doi:10.1158/0008-5472.CAN-11-3878
34. Aoi J, Endo M, Kadomatsu T, Miyata K, Ogata A, Horiguchi H, et al. Angiopoietin-like protein 2 accelerates carcinogenesis by activating chronic inflammation and oxidative stress. Mol Cancer Res (2013). doi:10.1158/1541-7786.MCR-13-0336
35. Farhat N, Thorin-Trescases N, Mamarbachi M, Villeneuve L, Yu C, Martel C, et al. Angiopoietin-like 2 promotes atherogenesis in mice. J Am Heart Assoc (2013) 2:e000201. doi:10.1161/JAHA.113.000201
36. Muramoto A, Tsushita K, Kato A, Ozaki T, Tabata Y, Endo A, et al. Angiopoietin-like protein 2 sensitively responds to weight reduction induced by lifestyle intervention on overweight Japanese men. Nutr Diabetes (2011) 1:e20. doi:10.1038/nutd.2011.16
37. Kitazawa M, Nagano M, Masumoto KH, Shigeyoshi Y, Natsume T, Hashimoto S. Angiopoietin-like 2, a circadian gene, improves type 2 diabetes through potentiation of insulin sensitivity in mice adipocytes. Endocrinology (2011) 152:2558-67. doi:10.1210/en.2010-1407
38. Ono M, Shimizugawa T, Shimamura M, Yoshida K, Noji-Sakikawa C, Ando Y, et al. Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo. J Biol Chem (2003) 278:41804-9. doi:10.1074/jbc. M302861200
39. Jin W, Wang X, Millar JS, Quertermous T, Rothblat GH, Glick JM, et al. Hepatic proprotein convertases modulate HDL metabolism. Cell Metab (2007) 6:129-36. doi:10.1016/j.cmet.2007.07.009
40. Essalmani R, Susan-Resiga D, Chamberland A, Asselin MC, Canuel M, Constam D, et al. Furin is the primary in vivo convertase of angiopoietin-like 3 and endothelial lipase in hepatocytes. J Biol Chem (2013) 288:26410-8. doi:10.1074/jbc. M113.501304
41. Robciuc MR, Maranghi M, Lahikainen A, Rader D, Bensadoun A, Oorni K, et al. Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids. Arterioscler Thromb Vasc Biol (2013) 33:1706-13. doi:10.1161/ATVBAHA.113.301397
42. Musunuru K, Pirruccello JP, Do R, Peloso GM, Guiducci C, Sougnez C, et al. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N Engl J Med (2010) 363:2220-7. doi:10.1056/NEJMoa1002926
43. Noto D, Cefalu AB, Valenti V, Fayer F, Pinotti E, Ditta M, et al. Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia. Arterioscler Thromb Vasc Biol (2012) 32:805-9. doi:10.1161/ATVBAHA.111.238766
44. Pisciotta L, Favari E, Magnolo L, Simonelli S, Adorni MP, Sallo R, et al. Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3. Circ Cardiovasc Genet (2012) 5:42-50. doi:10.1161/CIRCGENETICS.111.960674
45. Minicocci IP, Santini SM, Cantisani VM, Stitziel NP, Kathiresan SM, Arroyo JAM, et al. Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. J Lipid Res (2013) 54:3481-90. doi:10.1194/jlr. P039875
46. Shimamura M, Matsuda M, Yasumo H, Okazaki M, Fujimoto K, Kono K, et al. Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase. Arterioscler Thromb Vasc Biol (2007) 27:366-72. doi:10.1161/01.ATV.0000252827.51626.89
47. Fugier C, Tousaint JJ, Prieur X, Plateroti M, Samarut J, Delerive P. The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormone. J Biol Chem (2006) 281:11553-9. doi:10.1074/jbc. M512554200
48. Hayashi Y, Jinnin M, Makino T, Kajihara I, Makino K, Honda N, et al. Serum angiopoietin-like protein 3 concentrations in rheumatic diseases. Eur J Dermatol (2012) 22:500-4. doi:10.1684/ejd.2012.1774
49. Hatsuda S, Shoji T, Shinohara K, Kimoto E, Mori K, Fukumoto S, et al. Association between plasma angiopoietin-like protein 3 and arterial wall thickness in healthy subjects. J Vasc Res (2007) 44:61-6. doi:10.1159/000098153
50. Georgiadi A, Wang Y, Stienstra R, Tjeerdema N, Janssen A, Stalenhoef A, et al. Overexpression of angiopoietin-like protein 4 protects against atherosclerosis development. Arterioscler Thromb Vasc Biol (2013) 33:1529-37. doi:10.1161/ATVBAHA.113.301698
51. Makoveichuk E, Vorrsjo E, Olivecrona T, Olivecrona G. Inactivation of lipoprotein lipase in 3T3-L1 adipocytes by angiopoietin-like protein 4 requires that both proteins have reached the cell surface. Biochem Biophys Res Commun (2013) 441:941-6. doi:10.1016/j.bbrc.2013.11.013
52. Jonker JT, Smit JW, Hammer S, Snel M, Van Der Meer RW, Lamb HJ, et al. Dietary modulation of plasma angiopoietin-like protein 4 concentrations in healthy volunteers and in patients with type 2 diabetes. Am J Clin Nutr (2013) 97:255-60. doi:10.3945/ajcn.112.043687
53. Mandard S, Zandbergen F, Van Straten E, Wahli W, Kuipers F, Muller M, et al. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem (2006) 281:934-44. doi:10.1074/jbc. M506519200
54. Sanderson LM, Degenhardt T, Koppen A, Kalkhoven E, Desvergne B, Muller M, et al. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver. Mol Cell Biol (2009) 29:6257-67. doi:10.1128/MCB.00370-09
55. Robciuc MR, Naukkarinen J, Ortega-Alonso A, Tyynismaa H, Raivio T, Rissanen A, et al. Serum angiopoietin-like 4 protein levels and expression in adipose tissue are inversely correlated with obesity in monozygotic twins. J Lipid Res (2011) 52:1575-82. doi:10.1194/jlr. P015867
56. Ruge T, Sukonina V, Kroupa O, Makoveichuk E, Lundgren M, Svensson MK, et al. Effects of hyperinsulinemia on lipoprotein lipase, angiopoietin-like protein 4, and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in subjects with and without type 2 diabetes mellitus. Metabolism (2012) 61:652-60. doi:10.1016/j.metabol.2011.09.014
57. Mizutani N, Ozaki N, Seino Y, Fukami A, Sakamoto E, Fukuyama T, et al. Reduction of insulin signaling upregulates angiopoietin-like protein 4 through elevated free fatty acids in diabetic mice. Exp Clin Endocrinol Diabetes (2012) 120:139-44. doi:10.1055/s-0031-1291258
58. Van Raalte DH, Brands M, Serlie MJ, Mudde K, Stienstra R, Sauerwein HP, et al. Angiopoietin-like protein 4 is differentially regulated by glucocorticoids and insulin in vitro and in vivo in healthy humans. Exp Clin Endocrinol Diabetes (2012) 120:598-603. doi:10.1055/s-0032-1321864
59. Clement LC, Avila-Casado C, Mace C, Soria E, Bakker WW, Kersten S, et al. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med (2011) 17:117-22. doi:10.1038/nm.2261
60. Chugh SS, Clement LC, Mace C. New insights into human minimal change disease: lessons from animal models. Am J Kidney Dis (2012) 59:284-92. doi:10.1053/j.ajkd.2011.07.024
61. Clement LC, Mace C, Avila-Casado C, Joles JA, Kersten S, Chugh SS. Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome. Nat Med (2013) 20:37-46. doi:10.1038/nm.3396
62. Xu A, Lam MC, Chan KW, Wang Y, Zhang J, Hoo RL, et al. Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc Natl Acad Sci U S A (2005) 102:6086-91. doi:10.1073/pnas.0408452102
63. Kim HK, Youn BS, Shin MS, Namkoong C, Park KH, Baik JH, et al. Hypothalamic Angptl4/Fiaf is a novel regulator of food intake and body weight. Diabetes (2010) 59:2772-80. doi:10.2337/db10-0145
64. Katano H, Yamada K. Upregulation of ANGPTL4 messenger RNA and protein in severely calcified carotid plaques. J Stroke Cerebrovasc Dis (2013). doi:10.1016/j.jstrokecerebrovasdis.2013.07.046
65. Koishi R, Ando Y, Ono M, Shimamura M, Yasumo H, Fujiwara T, et al. Angptl3 regulates lipid metabolism in mice. Nat Genet (2002) 30:151-7. doi:10.1038/ng814
66. Romeo S, Yin W, Kozlitina J, Pennacchio LA, Boerwinkle E, Hobbs HH, et al. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J Clin Invest (2009) 119:70-9. doi:10.1172/JCI37118
67. Li C. Genetics and regulation of angiopoietin-like proteins 3 and 4. Curr Opin Lipidol (2006) 17:152-6. doi:10.1097/01.mol.0000217896.67444.05
68. Ge H, Cha JY, Gopal H, Harp C, Yu X, Repa JJ, et al. Differential regulation and properties of angiopoietin-like proteins 3 and 4. J Lipid Res (2005) 46:1484-90. doi:10.1194/jlr. M500005-JLR200
69. Zhang CC, Kaba M, Iizuka S, Huynh H, Lodish HF. Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. Blood (2008) 111:3415-23. doi:10.1182/blood-2007-11-122119
70. Khoury M, Drake A, Chen Q, Dong D, Leskov I, Fragoso MF, et al. Mesenchymal stem cells secreting angiopoietin-like-5 support efficient expansion of human hematopoietic stem cells without compromising their repopulating potential. Stem Cells Dev (2011) 20:1371-81. doi:10.1089/scd.2010.0456
71. Akhter S, Rahman MM, Lee HS, Kim HJ, Hong ST. Dynamic roles of angiopoietin-like proteins 1, 2, 3, 4, 6 and 7 in the survival and enhancement of ex vivo expansion of bone-marrow hematopoietic stem cells. Protein Cell (2013) 4:220-30. doi:10.1007/s13238-013-2066-5
72. Namkung J, Koh SB, Kong ID, Choi JW, Yeh BI. Serum levels of angiopoietin-related growth factor are increased in metabolic syndrome. Metabolism (2011) 60:564-8. doi:10.1016/j.metabol.2010.05.013
73. Oike Y, Akao M, Yasunaga K, Yamauchi T, Morisada T, Ito Y, et al. Angiopoietin-related growth factor antagonizes obesity and insulin resistance. Nat Med (2005) 11:400-8. doi:10.1038/nm1214
74. Legry V, Goumidi L, Huyvaert M, Cottel D, Ferrieres J, Arveiler D, et al. Association between angiopoietin-like 6 (ANGPTL6) gene polymorphisms and metabolic syndrome-related phenotypes in the French MONICA Study. Diabetes Metab (2009) 35:287-92. doi:10.1016/j.diabet.2008.12.005
75. Tuuri AL, Jauhiainen MS, Ehnholm CP, Tikkanen MJ, Nicholls MG, Kaaja RJ. Elevated serum angiopoietin-like protein 6 in women with subsequent pregnancy-induced hypertension: a preliminary study. Hypertens Pregnancy (2013) 32:203-13. doi:10.3109/10641955.2013.784783
76. Mirzaei K, Hossein-Nezhad A, Chamari M, Shahbazi S. Evidence of a role of ANGPTL6 in resting metabolic rate and its potential application in treatment of obesity. Minerva Endocrinol (2011) 36:13-21.
77. Santulli G, Totary-Jain H. Tailoring mTOR-based therapy: molecular evidence and clinical challenges. Pharmacogenomics (2013) 14:1517-26. doi:10.2217/pgs.13.143
78. Katoh Y, Katoh M. Comparative integromics on angiopoietin family members. Int J Mol Med (2006) 17:1145-9.
79. Kuchtey J, Kallberg ME, Gelatt KN, Rinkoski T, Komaromy AM, Kuchtey RW. Angiopoietin-like 7 secretion is induced by glaucoma stimuli and its concentration is elevated in glaucomatous aqueous humor. Invest Ophthalmol Vis Sci (2008) 49:3438-48. doi:10.1167/iovs.07-1347
80. Comes N, Buie LK, Borras T. Evidence for a role of angiopoietin-like 7 (ANGPTL7) in extracellular matrix formation of the human trabecular meshwork: implications for glaucoma. Genes Cells (2011) 16:243-59. doi:10.1111/j.1365-2443.2010.01483.x
81. Rozsa FW, Reed DM, Scott KM, Pawar H, Moroi SE, Kijek TG, et al. Gene expression profile of human trabecular meshwork cells in response to long-term dexamethasone exposure. Mol Vis (2006) 12:125-41.
82. Sacca SC, Izzotti A. Focus on molecular events in the anterior chamber leading to glaucoma. Cell Mol Life Sci (2013). doi:10.1007/s00018-013-1493-z
83. Ren G, Kim JY, Smas CM. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab (2012) 303:E334-51. doi:10.1152/ajpendo.00084.2012
84. Yi P, Park JS, Melton DA. Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell (2013) 153:747-58. doi:10.1016/j.cell.2013.04.008
85. Seymour PA, Serup P. Bulking up on beta cells. N Engl J Med (2013) 369:777-9. doi:10.1056/NEJMcibr1307038
86. Crunkhorn S. Metabolic disorders: betatrophin boosts beta-cells. Nat Rev Drug Discov (2013) 12:504. doi:10.1038/nrd4058
87. Kugelberg E. Diabetes: betatrophin - inducing beta-cell expansion to treat diabetes mellitus? Nat Rev Endocrinol (2013) 9:379. doi:10.1038/nrendo.2013.98